202 related articles for article (PubMed ID: 16772720)
1. Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants.
Kishimoto S; Oka S; Gokoh M; Sugiura T
Int Arch Allergy Immunol; 2006; 140 Suppl 1():3-7. PubMed ID: 16772720
[TBL] [Abstract][Full Text] [Related]
2. 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils.
Oka S; Ikeda S; Kishimoto S; Gokoh M; Yanagimoto S; Waku K; Sugiura T
J Leukoc Biol; 2004 Nov; 76(5):1002-9. PubMed ID: 15316028
[TBL] [Abstract][Full Text] [Related]
3. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K).
Mishra RK; Scaife JE; Harb Z; Gray BC; Djukanovic R; Dent G
Allergy; 2005 Sep; 60(9):1204-7. PubMed ID: 16076309
[TBL] [Abstract][Full Text] [Related]
4. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis.
Powell WS; Ahmed S; Gravel S; Rokach J
J Allergy Clin Immunol; 2001 Feb; 107(2):272-8. PubMed ID: 11174193
[TBL] [Abstract][Full Text] [Related]
5. Effect of emedastine difumarate on CC chemokine-elicited eosinophil migration.
Saito H; Yamamoto N; Tomita S; Taniguchi M; Hasegawa M; Akiyama K; Kawaguchi H; Takahashi K
Int Arch Allergy Immunol; 2001; 125 Suppl 1():22-8. PubMed ID: 11408768
[TBL] [Abstract][Full Text] [Related]
6. Hierarchy of eosinophil chemoattractants: role of p38 mitogen-activated protein kinase.
Schratl P; Sturm EM; Royer JF; Sturm GJ; Lippe IT; Peskar BA; Heinemann A
Eur J Immunol; 2006 Sep; 36(9):2401-9. PubMed ID: 16906532
[TBL] [Abstract][Full Text] [Related]
7. Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate.
El-Shazly A; Masuyama K; Samejima Y; Eura M; Ishikawa T
Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():10-3. PubMed ID: 9758889
[TBL] [Abstract][Full Text] [Related]
8. IL-16 activates plasminogen-plasmin system and promotes human eosinophil migration into extracellular matrix via CCR3-chemokine-mediated signaling and by modulating CD4 eosinophil expression.
Ferland C; Flamand N; Davoine F; Chakir J; Laviolette M
J Immunol; 2004 Oct; 173(7):4417-24. PubMed ID: 15383572
[TBL] [Abstract][Full Text] [Related]
9. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils.
Nagata M; Saito K; Kikuchi I; Hagiwara K; Kanazawa M
Int Arch Allergy Immunol; 2005; 137 Suppl 1():2-6. PubMed ID: 15947477
[TBL] [Abstract][Full Text] [Related]
10. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
11. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils.
Elsner J; Höchstetter R; Kimmig D; Kapp A
Eur J Immunol; 1996 Aug; 26(8):1919-25. PubMed ID: 8765040
[TBL] [Abstract][Full Text] [Related]
12. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils.
El-Shazly A; Masuyama K; Nakano K; Eura M; Samejima Y; Ishikawa T
Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():55-8. PubMed ID: 9758899
[TBL] [Abstract][Full Text] [Related]
13. Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells.
Umland SP; Wan Y; Shortall J; Shah H; Jakway J; Garlisi CG; Tian F; Egan RW; Billah MM
J Leukoc Biol; 2000 Mar; 67(3):441-7. PubMed ID: 10733106
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil activation by eotaxin--eotaxin primes the production of reactive oxygen species from eosinophils.
Honda K; Chihara J
Allergy; 1999 Dec; 54(12):1262-9. PubMed ID: 10688429
[TBL] [Abstract][Full Text] [Related]
15. Effect of extracellular matrix proteins on platelet-activating factor-induced eosinophil chemotaxis.
Yoshikawa M; Matsumoto K; Iida M; Akasawa A; Moriyama H; Saito H
Int Arch Allergy Immunol; 2002; 128 Suppl 1():3-11. PubMed ID: 12065903
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
Erger RA; Casale TB
Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
[TBL] [Abstract][Full Text] [Related]
17. Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin.
Teixeira MM; Wells TN; Lukacs NW; Proudfoot AE; Kunkel SL; Williams TJ; Hellewell PG
J Clin Invest; 1997 Oct; 100(7):1657-66. PubMed ID: 9312163
[TBL] [Abstract][Full Text] [Related]
18. CC-chemokine receptor 3: a possible target in treatment of allergy-related corneal ulcer.
Fukagawa K; Okada N; Fujishima H; Nakajima T; Tsubota K; Takano Y; Kawasaki H; Saito H; Hirai K
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):58-62. PubMed ID: 11773013
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice.
Frei RB; Luschnig P; Parzmair GP; Peinhaupt M; Schranz S; Fauland A; Wheelock CE; Heinemann A; Sturm EM
Allergy; 2016 Jul; 71(7):944-56. PubMed ID: 26850094
[TBL] [Abstract][Full Text] [Related]
20. The GM-CSF analogue E21R induces apoptosis of normal and activated eosinophils.
Iversen PO; Robinson D; Ying S; Meng Q; Kay AB; Clark-Lewis I; Lopez AF
Am J Respir Crit Care Med; 1997 Nov; 156(5):1628-32. PubMed ID: 9372686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
